Comprehensive Breast Cancer Risk Assessment for


Journal

JCO precision oncology
ISSN: 2473-4284
Titre abrégé: JCO Precis Oncol
Pays: United States
ID NLM: 101705370

Informations de publication

Date de publication:
06 2021
Historique:
received: 24 11 2020
revised: 06 05 2021
accepted: 19 05 2021
entrez: 29 7 2021
pubmed: 30 7 2021
medline: 30 7 2021
Statut: epublish

Résumé

Breast cancer risks for This study included deidentified clinical records from 358,095 women of European ancestry who received testing with a multigene panel (September 2013 to November 2019). Model development included ORs for association of PV status with breast cancer were 2.01 (95% CI, 1.88 to 2.16) and 1.83 (95% CI, 1.68 to 2.00) for In

Identifiants

pubmed: 34322652
doi: 10.1200/PO.20.00484
pii: PO.20.00484
pmc: PMC8238281
pii:
doi:

Substances chimiques

Checkpoint Kinase 2 EC 2.7.1.11
ATM protein, human EC 2.7.11.1
Ataxia Telangiectasia Mutated Proteins EC 2.7.11.1
CHEK2 protein, human EC 2.7.11.1

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Subventions

Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States

Informations de copyright

© 2021 by American Society of Clinical Oncology.

Déclaration de conflit d'intérêts

Shannon Gallagher Employment: Myriad Genetics Stock and Other Ownership Interests: Myriad Genetics Elisha Hughes Employment: Myriad Genetics Stock and Other Ownership Interests: Myriad Genetics Allison W. Kurian Research Funding: Myriad Genetics Other Relationship: Ambry Genetics, Color Genomics, GeneDx/BioReference, InVitae, Genentech Susan M. Domchek Honoraria: AstraZeneca, Clovis Oncology, Bristol Myers Squibb Research Funding: AstraZeneca, Clovis Oncology Open Payments Link: https://openpaymentsdata.cms.gov/physician/917904 Judy Garber Consulting or Advisory Role: Novartis, GTx, Helix BioPharma, Konica Minolta, Aleta BioTherapeutics, H3 Biomedicine, Kronos Bio Research Funding: Novartis, Ambry Genetics, InVitae, Myriad Genetics Other Relationship: Susan G. Komen for the Cure, AACR, Diana Helis Henry Medical Foundation, James P. Wilmot Foundation, Adrienne Helis Malvin Medical Research Foundation, Breast Cancer Research Foundation, Facing Our Risk of Cancer Empowered Braden Probst Employment: Myriad Genetics Brian Morris Employment: Myriad Genetics Stock and Other Ownership Interests: Myriad Genetics Placede Tshiaba Employment: Myriad Genetics Stock and Other Ownership Interests: Myriad Genetics Stephanie Meek Employment: Myriad Genetics Stock and Other Ownership Interests: Myriad Genetics Eric Rosenthal Employment: Myriad Genetics Stock and Other Ownership Interests: Myriad Genetics Benjamin Roa Employment: Myriad Genetics Leadership: Myriad Genetics Stock and Other Ownership Interests: Myriad Genetics Research Funding: Myriad Genetics Patents, Royalties, Other Intellectual Property: Intellectual Property held by employer Myriad Genetics Travel, Accommodations, Expenses: Myriad Genetics Thomas P. Slavin Employment: Myriad Genetics Leadership: Myriad Genetics Stock and Other Ownership Interests: Myriad Genetics Susanne Wagner Employment: Myriad Genetics Stock and Other Ownership Interests: Myriad Genetics Patents, Royalties, Other Intellectual Property: Co-author of patents held by Myriad Genetics, no royalties Jeffrey Weitzel Speakers' Bureau: AstraZeneca Alexander Gutin Employment: Myriad Genetics Stock and Other Ownership Interests: Myriad Genetics, Gilead Sciences Jerry S. Lanchbury Employment: Myriad Genetics Leadership: Myriad Genetics Stock and Other Ownership Interests: Myriad Genetics Patents, Royalties, Other Intellectual Property: I am an inventor on Multiple patents filed by Myriad Genetics Travel, Accommodations, Expenses: Myriad Genetics Mark Robson Consulting or Advisory Role: Change HealthCare Research Funding: AstraZeneca, Pfizer, Merck Other Relationship: Research to Practice, Clinical Care Options, Physicans' Education Resource, Invitae, Pfizer Uncompensated Relationships: Merck, Pfizer, Daiichi Sankyo, Epic Sciences Open Payments Link: https://openpaymentsdata.cms.gov/physician/612669/summary No other potential conflicts of interest were reported.Shannon Gallagher Employment: Myriad Genetics Stock and Other Ownership Interests: Myriad Genetics Elisha Hughes Employment: Myriad Genetics Stock and Other Ownership Interests: Myriad Genetics Allison W. Kurian Research Funding: Myriad Genetics Other Relationship: Ambry Genetics, Color Genomics, GeneDx/BioReference, InVitae, Genentech Susan M. Domchek Honoraria: AstraZeneca, Clovis Oncology, Bristol Myers Squibb Research Funding: AstraZeneca, Clovis Oncology Open Payments Link: https://openpaymentsdata.cms.gov/physician/917904 Judy Garber Consulting or Advisory Role: Novartis, GTx, Helix BioPharma, Konica Minolta, Aleta BioTherapeutics, H3 Biomedicine, Kronos Bio Research Funding: Novartis, Ambry Genetics, InVitae, Myriad Genetics Other Relationship: Susan G. Komen for the Cure, AACR, Diana Helis Henry Medical Foundation, James P. Wilmot Foundation, Adrienne Helis Malvin Medical Research Foundation, Breast Cancer Research Foundation, Facing Our Risk of Cancer Empowered Braden Probst Employment: Myriad Genetics Brian Morris Employment: Myriad Genetics Stock and Other Ownership Interests: Myriad Genetics Placede Tshiaba Employment: Myriad Genetics Stock and Other Ownership Interests: Myriad Genetics Stephanie Meek Employment: Myriad Genetics Stock and Other Ownership Interests: Myriad Genetics Eric Rosenthal Employment: Myriad Genetics Stock and Other Ownership Interests: Myriad Genetics Benjamin Roa Employment: Myriad Genetics Leadership: Myriad Genetics Stock and Other Ownership Interests: Myriad Genetics Research Funding: Myriad Genetics Patents, Royalties, Other Intellectual Property: Intellectual Property held by employer Myriad Genetics Travel, Accommodations, Expenses: Myriad Genetics Thomas P. Slavin Employment: Myriad Genetics Leadership: Myriad Genetics Stock and Other Ownership Interests: Myriad Genetics Susanne Wagner Employment: Myriad Genetics Stock and Other Ownership Interests: Myriad Genetics Patents, Royalties, Other Intellectual Property: Co-author of patents held by Myriad Genetics, no royalties Jeffrey Weitzel Speakers' Bureau: AstraZeneca Alexander Gutin Employment: Myriad Genetics Stock and Other Ownership Interests: Myriad Genetics, Gilead Sciences Jerry S. Lanchbury Employment: Myriad Genetics Leadership: Myriad Genetics Stock and Other Ownership Interests: Myriad Genetics Patents, Royalties, Other Intellectual Property: I am an inventor on Multiple patents filed by Myriad Genetics Travel, Accommodations, Expenses: Myriad Genetics Mark Robson Consulting or Advisory Role: Change HealthCare Research Funding: AstraZeneca, Pfizer, Merck Other Relationship: Research to Practice, Clinical Care Options, Physicans' Education Resource, Invitae, Pfizer Uncompensated Relationships: Merck, Pfizer, Daiichi Sankyo, Epic Sciences Open Payments Link: https://openpaymentsdata.cms.gov/physician/612669/summary No other potential conflicts of interest were reported.

Références

J Natl Cancer Inst. 2015 Apr 08;107(5):
pubmed: 25855707
JAMA. 2017 Jun 20;317(23):2402-2416
pubmed: 28632866
J Clin Oncol. 2008 Feb 1;26(4):542-8
pubmed: 18172190
Am J Hum Genet. 2019 Jan 3;104(1):21-34
pubmed: 30554720
J Natl Cancer Inst. 2006 Apr 19;98(8):535-44
pubmed: 16622123
CA Cancer J Clin. 2007 Mar-Apr;57(2):75-89
pubmed: 17392385
Med Clin North Am. 2017 Jul;101(4):725-741
pubmed: 28577623
Genet Med. 2020 Nov;22(11):1803-1811
pubmed: 32624571
J Clin Oncol. 2011 Oct 1;29(28):3747-52
pubmed: 21876083
JCO Precis Oncol. 2021 Jan 28;5:
pubmed: 34036224
Breast Cancer Res Treat. 2018 Feb;167(3):779-785
pubmed: 29116468
J Natl Cancer Inst. 2020 Jun 1;112(6):590-598
pubmed: 31553449
Genet Med. 2020 Oct;22(10):1653-1666
pubmed: 32665703
J Natl Cancer Inst. 2017 Jul 1;109(7):
pubmed: 28376175
Oncotarget. 2017 Oct 31;8(60):102110-102118
pubmed: 29254229
Genet Med. 2017 May;19(5):599-603
pubmed: 27711073
BMC Cancer. 2015 Apr 02;15:215
pubmed: 25886519
JCO Precis Oncol. 2020 Jun 8;4:
pubmed: 32923876
JAMA Netw Open. 2020 Jul 1;3(7):e208501
pubmed: 32609350
J Clin Oncol. 2020 Mar 1;38(7):674-685
pubmed: 31841383
Oncotarget. 2017 Feb 7;8(6):9144-9154
pubmed: 27880720
J Clin Oncol. 2016 Aug 10;34(23):2750-60
pubmed: 27269948

Auteurs

Shannon Gallagher (S)

Myriad Genetics Inc, Salt Lake City, UT.

Elisha Hughes (E)

Myriad Genetics Inc, Salt Lake City, UT.

Allison W Kurian (AW)

Stanford University School of Medicine, Stanford, CA.

Susan M Domchek (SM)

University of Pennsylvania School of Medicine, Philadelphia, PA.

Judy Garber (J)

Dana-Farber Cancer Institute, Boston, MA.

Braden Probst (B)

Myriad Genetics Inc, Salt Lake City, UT.

Brian Morris (B)

Myriad Genetics Inc, Salt Lake City, UT.

Placede Tshiaba (P)

Myriad Genetics Inc, Salt Lake City, UT.

Stephanie Meek (S)

Myriad Genetics Inc, Salt Lake City, UT.

Eric Rosenthal (E)

Myriad Genetics Inc, Salt Lake City, UT.

Benjamin Roa (B)

Myriad Genetics Inc, Salt Lake City, UT.

Thomas P Slavin (TP)

Myriad Genetics Inc, Salt Lake City, UT.

Susanne Wagner (S)

Myriad Genetics Inc, Salt Lake City, UT.

Jeffrey Weitzel (J)

City of Hope, Duarte, CA.

Alexander Gutin (A)

Myriad Genetics Inc, Salt Lake City, UT.

Jerry S Lanchbury (JS)

Myriad Genetics Inc, Salt Lake City, UT.

Mark Robson (M)

Memorial Sloan Kettering Cancer Center, New York City, NY.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH